Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel

Interreader agreement and variability of FDG PET volumetric parameters in human solid tumors.

Publication ,  Journal Article
Paidpally, V; Mercier, G; Shah, BA; Senthamizhchelvan, S; Subramaniam, RM
Published in: Ajr Am J Roentgenol
February 2014

OBJECTIVE: The purpose of this article is to evaluate the interreader agreement and variability of two (18)F-FDG PET parameters, metabolic tumor volume and total lesion glycolysis, in human solid tumors. MATERIALS AND METHODS: One hundred eleven patients (mean [± SD] age, 61.9 ± 12.5 years) with baseline staging FDG PET/CT scans were included. Two readers independently read the scans and segmented metabolic tumor volume and total lesion glycolysis using two fixed thresholds, 40% and 50% of the lesion's maximum standardized uptake value (SUVmax). The impact of the lesion's FDG avidity and location on reader agreement and variability was established. Intraclass correlation coefficient (ICC), precision, and Bland-Altman analysis were used to evaluate agreement and variability. RESULTS: The ICCs for 40% and 50% SUVmax segmentations of metabolic tumor volume between the readers were 0.987 and 0.995, and the corresponding values for 40% and 50% SUVmax segmentations of total lesion glycolysis were 0.987 and 0.986, respectively (p = 0.0001). The corresponding precisions were 0.5%, 0.2%, 0.5%, and 0.5%, respectively. The mean biases between the readers for 40% and 50% SUVmax segmentations of metabolic tumor volume were -1.78 ± 8.42 mL and -0.46 ± 2.1 mL and for 40% and 50% SUVmax segmentations of total lesion glycolysis were -7.3 ± 31.6 g and -2.97 ± 12.86 g, respectively. Subgroup analysis showed better precision and lesser variability for 50% SUVmax segmentations of metabolic tumor volume and total lesion glycolysis in patients with the highest and lowest FDG-avid primary tumors. The precision was highest and variability was lowest for lung tumors. CONCLUSION: There is excellent interreader agreement for measurement of metabolic tumor volume and total lesion glycolysis with 40% and 50% SUVmax threshold segmentations in human solid tumors.

Duke Scholars

Published In

Ajr Am J Roentgenol

DOI

EISSN

1546-3141

Publication Date

February 2014

Volume

202

Issue

2

Start / End Page

406 / 412

Location

United States

Related Subject Headings

  • Tumor Burden
  • Tomography, X-Ray Computed
  • Radiopharmaceuticals
  • Positron-Emission Tomography
  • Nuclear Medicine & Medical Imaging
  • Neoplasms
  • Multimodal Imaging
  • Middle Aged
  • Male
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Paidpally, V., Mercier, G., Shah, B. A., Senthamizhchelvan, S., & Subramaniam, R. M. (2014). Interreader agreement and variability of FDG PET volumetric parameters in human solid tumors. Ajr Am J Roentgenol, 202(2), 406–412. https://doi.org/10.2214/AJR.13.10841
Paidpally, Vasavi, Gustavo Mercier, Bhartesh A. Shah, Srinivasan Senthamizhchelvan, and Rathan M. Subramaniam. “Interreader agreement and variability of FDG PET volumetric parameters in human solid tumors.Ajr Am J Roentgenol 202, no. 2 (February 2014): 406–12. https://doi.org/10.2214/AJR.13.10841.
Paidpally V, Mercier G, Shah BA, Senthamizhchelvan S, Subramaniam RM. Interreader agreement and variability of FDG PET volumetric parameters in human solid tumors. Ajr Am J Roentgenol. 2014 Feb;202(2):406–12.
Paidpally, Vasavi, et al. “Interreader agreement and variability of FDG PET volumetric parameters in human solid tumors.Ajr Am J Roentgenol, vol. 202, no. 2, Feb. 2014, pp. 406–12. Pubmed, doi:10.2214/AJR.13.10841.
Paidpally V, Mercier G, Shah BA, Senthamizhchelvan S, Subramaniam RM. Interreader agreement and variability of FDG PET volumetric parameters in human solid tumors. Ajr Am J Roentgenol. 2014 Feb;202(2):406–412.

Published In

Ajr Am J Roentgenol

DOI

EISSN

1546-3141

Publication Date

February 2014

Volume

202

Issue

2

Start / End Page

406 / 412

Location

United States

Related Subject Headings

  • Tumor Burden
  • Tomography, X-Ray Computed
  • Radiopharmaceuticals
  • Positron-Emission Tomography
  • Nuclear Medicine & Medical Imaging
  • Neoplasms
  • Multimodal Imaging
  • Middle Aged
  • Male
  • Humans